Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: multiple sclerosis,treatment of (Click to remove) Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999 NEJM 340:945-953, , 1999 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis JAMA Neurol 73:757-759, Penkert, H.,et al, 2016 Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS Neurol 77:2010-2016, Kuhle, J.,et al, 2011 Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis Neurol 74:521-523, Gutwinski,S.,et al, 2010 Tumefactive Demyelination: An Approach to Diagnosis and Management JNNP 84:1047-1053, Hardy, T.A. & Chataway, J., 2009 Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab NEJM 353:375-381, Langer-Gould,A.,et al, 2005 Stereotaxic Thalamotomy-Experiences from the Levodopa Era JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990 Pain in Multiple Sclerosis Arch Neurol 41:1270-1272, Clifford,D.B.,et al, 1984 Showing articles 0 to 9 of 9